Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Histological Typing of Endocrine Tumours
2000 • 741 citations
Molecular pharmacology of somatostatin receptor subtypes
1997 • 411 citations
Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts
1990 • 317 citations
Expression of vascular endothelial growth factor in digestive neuroendocrine tumours
1998 • 271 citations
Treatment of Neuroendocrine GEP Tumours with Somatostatin Analogues
2000 • 160 citations
Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
1997 • 137 citations
Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
1998 • 136 citations
Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors
1999 • 135 citations
Somatostatin Activation of Mitogen-Activated Protein Kinase via Somatostatin Receptor 1 (SSTR1)
1999 • 134 citations
Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation.
1998 • 129 citations
Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas
2000 • 127 citations
Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells
1998 • 123 citations
Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours
1998 • 118 citations
sst2 Somatostatin Receptor Mediates Negative Regulation of Insulin Receptor Signaling through the Tyrosine Phosphatase SHP-1
1998 • 113 citations
Role of disease‐causing genes in sporadic pancreatic endocrine tumors: MEN1 andVHL
2001 • 105 citations
Genotype/Phenotype Correlation of Multiple Endocrine Neoplasia Type 1 Gene Mutations in Sporadic Gastrinomas
2000 • 102 citations
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p
1998 • 85 citations
Somatostatin Receptors
2000 • 82 citations
p27: A potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior
2001 • 70 citations
Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis
1995 • 62 citations
Expression of Growth Factors and Their Receptors in Neuroendocrine Gut and Pancreatic Tumors, and Prognostic Factors for Survival
1994 • 57 citations
Antitumor Effect of a Neutralizing Antibody to Vascular Endothelial Growth Factor on Liver Metastasis of Endocrine Neoplasm
1998 • 48 citations
p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells.
1996 • 40 citations
Mack Forster Award Lecture Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients
1997 • 37 citations
Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells
1995 • 28 citations
Long-term octreotide treatment of metastatic carcinoid tumor
2000 • 19 citations
Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours
1998 • 14 citations
Advances in Pancreatic Disease, Molecular Biology, Diagnosis and Treatment
1997 • 12 citations
Inhibition of L-Type Calcium Channels by Octreotide in Isolated Human Neuroendocrine Tumor Cells of the Gut
1998 • 11 citations